This is the authors' abstract. We don't add key points for this paper.
The authors describe 12 neuroleptic-treated patients with dementia of various etiologies who showed CSF elevation of phosphorylated 14-3-3zeta and normal tau protein levels. This contrasted with elevated amounts of 14-3-3 gamma, epsilon, and unphosphorylated zeta coupled to high tau protein levels in Creutzfeldt-Jakob disease and negative 14-3-3 assay in drug-free patients with dementia. Characterization of CSF 14-3-3 isoforms and determination of tau protein level can help to distinguish different etiologies of dementia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zanusso et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: